- Home
- ENLT vs STAA Comparison
ENLT vs STAA Comparison
Compare ENLT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLT
- STAA
- Stock Information
- Founded
- ENLT 2008
- STAA 1982
- Country
- ENLT Israel
- STAA United States
- Employees
- ENLT N/A
- STAA N/A
- Industry
- ENLT
- STAA Ophthalmic Goods
- Sector
- ENLT
- STAA Health Care
- Exchange
- ENLT Nasdaq
- STAA Nasdaq
- Market Cap
- ENLT 2.7B
- STAA 850.9M
- IPO Year
- ENLT 2023
- STAA N/A
- Fundamental
- Price
- ENLT $25.10
- STAA $17.17
- Analyst Decision
- ENLT Buy
- STAA Hold
- Analyst Count
- ENLT 3
- STAA 8
- Target Price
- ENLT $19.67
- STAA $27.17
- AVG Volume (30 Days)
- ENLT 48.6K
- STAA 746.9K
- Earning Date
- ENLT 08-06-2025
- STAA 08-06-2025
- Dividend Yield
- ENLT N/A
- STAA N/A
- EPS Growth
- ENLT 90.47
- STAA N/A
- EPS
- ENLT 0.98
- STAA N/A
- Revenue
- ENLT $397,296,000.00
- STAA $279,134,000.00
- Revenue This Year
- ENLT $355.90
- STAA N/A
- Revenue Next Year
- ENLT $42.83
- STAA $29.34
- P/E Ratio
- ENLT $24.84
- STAA N/A
- Revenue Growth
- ENLT 44.42
- STAA N/A
- 52 Week Low
- ENLT $14.01
- STAA $13.50
- 52 Week High
- ENLT $26.27
- STAA $49.86
- Technical
- Relative Strength Index (RSI)
- ENLT 66.62
- STAA 49.02
- Support Level
- ENLT $24.60
- STAA $16.52
- Resistance Level
- ENLT $26.27
- STAA $18.00
- Average True Range (ATR)
- ENLT 0.52
- STAA 0.69
- MACD
- ENLT 0.12
- STAA 0.09
- Stochastic Oscillator
- ENLT 76.36
- STAA 53.85
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, which produces its revenue from the sale of the electricity that is produced through wind energy and solar energy in Europe.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.